Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06053736 · ClinicalTrials.gov registry record · NA
1-Week Dispensing Evaluation of REVIVE™ Toric Soft Contact Lenses
A NA study, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT06053736 is a NA study that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 26 participants.
The verdict
NCT06053736, a NA study, has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
Experienced soft contact lens wearing subjects will be enrolled in this 1-week, post-market, bilateral, repeated measures, dispensing study. All subjects will be seen for a Screening/Dispensing Visit at which informed consent will be obtained and eligibility will be assessed. If subjects satisfy all eligibility criteria and none of the exclusion criteria, subjects will be fit and dispensed study lenses. If unsuccessful in the dispensed lenses, additional lenses may be trialed. Once vision and lens fit are determined to be acceptable, eligible subjects will wear study lenses in both eyes for at least 8 hours per day (with the exception of the follow-up visits where the lenses should be worn for a minimum of 2 hours), for approximately 1 week (7 days +/-3 days). Measurements will be taken at the insertion visit and at the 7-day follow-up visit.
Interventions
- DEVICE REVIVE Contact Lens
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2023-10-04 |
| Est. Completion | 2023-12-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06053736
The ClinicalTrials.gov registry entry for NCT06053736 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch & Lomb Incorporated, which has 174 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which REVIVE Contact Lens is the first listed.
NCT06053736 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06053736 about?
NCT06053736 is a clinical study titled "1-Week Dispensing Evaluation of REVIVE™ Toric Soft Contact Lenses". Experienced soft contact lens wearing subjects will be enrolled in this 1-week, post-market, bilateral, repeated measures, dispensing study. All subjects will be seen for a Screening/Dispensing Visit at which informed consent will be obtained and eligibility will be assessed. If subjects satisfy all...
What is the current status of trial NCT06053736?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2023-10-04. Estimated completion is 2023-12-15.
What interventions are being tested in trial NCT06053736?
The interventions under investigation include: REVIVE Contact Lens (DEVICE).
Who is sponsoring clinical trial NCT06053736?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.